Related Experiment Video
Updated: Jul 25, 2026
09:48
Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques
Published on: June 30, 2017
7.8K
Single-cell and spatial transcriptomic characterization of pulmonary pleomorphic carcinoma
Atsushi Matsuoka1, Kazuhiko Shien2, Shuta Tomida3
1Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Communications Biology
|December 16, 2025
Summary
This study reveals key molecular insights into pulmonary pleomorphic carcinoma (PPC), a rare lung cancer. Researchers identified specific gene alterations and cell dynamics, offering potential new therapeutic targets for this aggressive disease.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Pulmonary pleomorphic carcinoma (PPC) is a rare lung cancer with both epithelial and sarcomatoid elements.
- The underlying molecular mechanisms and cellular interactions in PPC are poorly understood.
- Identifying novel therapeutic targets is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the molecular basis and cellular dynamics of PPC using multi-omics approaches.
- To identify potential therapeutic targets by analyzing gene alterations and cell populations.
- To understand the interplay between epithelial and sarcomatoid components in PPC.
Main Methods:
- Multi-omics analysis including digital spatial profiling and single-cell RNA sequencing (scRNA-seq).
- Analysis of driver gene alterations such as MET exon 14 skipping (METex14) and ALK fusion.
- Spatial transcriptomics to examine gene and protein expression in different cellular components.
Main Results:
- PPC shows diverse driver gene alterations, including METex14 and ALK fusion.
- MET gene and protein overexpression are localized to the epithelial component, even with METex14.
- Evidence of epithelial-mesenchymal transition (EMT) and extracellular matrix (ECM) remodeling between components.
- scRNA-seq identified epithelial cell populations with intermediate EMT states driving sarcomatoid component transformation and differentiation.
Conclusions:
- Specific epithelial cell populations with EMT and ECM remodeling signatures are potential therapeutic targets in PPC.
- Understanding the molecular heterogeneity and cellular crosstalk is key for developing targeted therapies for PPC.
- This study provides a foundation for novel therapeutic strategies against pulmonary pleomorphic carcinoma.
